Ye Jinbao, Yan La, Yuan Yu, Fu Fang, Yuan Lu, Fan Xinxin, Zhou Juanyu, Zhu Yuedan, Liu Xingzhu, Ren Gang, Chen Haiyang
Laboratory of Stem cell and anti-Aging Research, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Respiratory Health and Multimorbidity and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Life Med. 2024 Jun 28;3(3):lnae025. doi: 10.1093/lifemedi/lnae025. eCollection 2024 Jun.
The decline in intestinal stem cell (ISC) function is a hallmark of aging, contributing to compromised intestinal regeneration and increased incidence of age-associated diseases. Novel therapeutic agents that can rejuvenate aged ISCs are of paramount importance for extending healthspan. Here, we report on the discovery of Chrysosplenosides I and A (CAs 1 & 2), flavonol glycosides from the Xizang medicinal plant Maxim., which exhibit potent anti-aging effects on ISCs. Our research, using models, reveals that CAs 1 & 2 treatments not only restrain excessive ISC proliferation, thereby preserving intestinal homeostasis, but also extend the lifespan of aging . In aged mouse intestinal organoids, CAs 1 & 2 enhance the growth and budding of intestinal organoids, indicating improved regenerative capacity. Mechanistic investigations show that CAs 1 & 2 exert their effects by activating the peroxisome proliferator-activated receptor-gamma (PPARγ) and concurrently inhibiting the epidermal growth factor receptor (EGFR) signaling pathways. Our findings position CAs 1 & 2 as promising candidates for ameliorating ISC aging and suggest that targeting PPARγ, in particular, may offer a therapeutic strategy to counteract age-related intestinal dysfunction.
肠道干细胞(ISC)功能衰退是衰老的一个标志,会导致肠道再生能力受损以及与年龄相关疾病的发病率增加。能够使衰老的ISC恢复活力的新型治疗药物对于延长健康寿命至关重要。在此,我们报告从西藏药用植物绵参中发现的黄酮醇苷金腰子苷I和A(CA 1和CA 2),它们对ISC具有强大的抗衰老作用。我们利用模型进行的研究表明,CA 1和CA 2处理不仅能抑制ISC的过度增殖,从而维持肠道内稳态,还能延长衰老ISC的寿命。在老年小鼠肠道类器官中,CA 1和CA 2可增强肠道类器官的生长和出芽,表明再生能力得到改善。机制研究表明,CA 1和CA 2通过激活过氧化物酶体增殖物激活受体γ(PPARγ)并同时抑制表皮生长因子受体(EGFR)信号通路发挥作用。我们的研究结果将CA 1和CA 2定位为改善ISC衰老的有前景的候选药物,并表明靶向PPARγ尤其可能提供一种对抗与年龄相关的肠道功能障碍的治疗策略。